PE exits
Healthcare
Did PE firm OrbiMed beat the benchmark in latest India exit move?
Healthcare-focussed private equity investor OrbiMed has hit the sell button on a five-year-old portfolio firm in India after harvesting money from ......
Finance
How impact investor Lightrock hit a gold mine in latest India exit
Impact-oriented private equity firm Lightrock, which is an investor in several Indian companies such as MediBuddy, Shiprocket, Niyo, Scaler, Porter ......
Finance
Ares Asia spins high returns from India portfolio after a string of flops
Private equity-style alternative investment firm Ares Asia, formerly Ares SSG, which began life after US-based Ares Management acquired SSG Capital ......
Finance
Madison beats benchmark return on another exit as it courts LPs for new fund
Private equity firm Madison India Capital, which floated a new fund in 2023 about six years after it closed its fourth investment ......
TMT
Blackstone scores another hit after India blockbuster
Blackstone, which was among the top deck of private equity firms monetizing investments in India last year, has hit the sell button ......
Manufacturing
How did TPG fare in latest exit from India manufacturing portfolio?
Private equity firm TPG has made another liquidity move from its India portfolio, as it continues to generate returns from ......
Finance
TA Associates logs out of BFSI portfolio firm with spectacular returns
Private equity firm TA Associates, which clocked high returns from an Indian company earlier this year and scored a dud from ......
Finance
Affirma Capital lines up another exit from India portfolio
Emerging markets-focused private equity firm Affirma Capital has lined up another exit from its India portfolio, as it looks to return capital to its limited ......
Healthcare
How did Investcorp's latest India exit move pan out?
Bahrain-based alternative asset manager Investcorp has made its second India exit move of 2024, adding to its harvests last year ......
Healthcare
Kedaara Capital makes a quiet exit. Did it make any money?
Private equity firm Kedaara Capital has sold its entire stake in a pharmaceutical company, marking an exit from its maiden ......